Download as pdf or txt
Download as pdf or txt
You are on page 1of 56

2014 ESC / ESA guidelines on

non-cardiac surgery:
cardiovascular assessment and management

Stefan De Hert, MD, PhD


Department of Anesthesiology
Ghent University Hospital
Ghent University
Belgium
© 2010 Universitair Ziekenhuis Gent
disclosures ?

© 2010 Universitair Ziekenhuis Gent 2


disclosures ?
member, ESA Guidelines Committee

member, 2009 ESC/ESA Task Force for Preoperative Cardiac Risk


Assessment and Perioperative Cardiac Management in Non-cardiac
surgery
Eur Heart J 2009; 30: 2769 – 2812
Eur J Anaesthesiol 2010; 27: 92 – 137

chair, ESA Task Force on Preoperative evaluation of the adult patient


undergoing non-cardiac surgery
Eur J Anaesthesiol 2011; 28: 684 – 722

member, 2014 ESC/ESA joint task Force on Non-cardiac surgery:


cardiovascular assessment and management
Eur Heart J 2014; 35: 2383 – 2431
Eur J Anaesthesiol 2014 ; 31: 517 – 573

chair, ESA Task Force for the revision of the 2011 guidelines on
preoperative evaluation of the adult patient undergoing non-cardiac
surgery
© 2010 Universitair Ziekenhuis Gent 3
why new guidelines ?

© 2010 Universitair Ziekenhuis Gent 4


© 2010 Universitair Ziekenhuis Gent 5
© 2010 Universitair Ziekenhuis Gent 6
© 2010 Universitair Ziekenhuis Gent 7
© 2010 Universitair Ziekenhuis Gent 8
what is new ?

© 2010 Universitair Ziekenhuis Gent 9


© 2010 Universitair Ziekenhuis Gent 10
what is new ?

è role of the anesthesiologists

è evaluation of surgical risk

è pre-operative risk scores

è ECG and echocardiography

è pharmacological risk reduction strategies

è intra- and postoperative anesthetic management


© 2010 Universitair Ziekenhuis Gent 11
role of the anesthesiologists (society)

© 2010 Universitair Ziekenhuis Gent 12


role of the anesthesiologists (society)

© 2010 Universitair Ziekenhuis Gent 13


© 2010 Universitair Ziekenhuis Gent 14
evaluation of surgical risk

© 2010 Universitair Ziekenhuis Gent 15


ACC / AHA guidelines

emergent è intervention within 6 hrs


urgent è delay: 6 and 24 hrs
time sensitive è delay: >1 to 6 weeks
elective è delay up to 1yr

LOW risk è risk of MACE < 1%


HIGH risk è risk of MACE ≥ 1%

© 2010 Universitair Ziekenhuis Gent 16


ESC / ESA guidelines

© 2010 Universitair Ziekenhuis Gent 17


variety of surgical procedures
in different clinical contexts

è difficult to assign a specific risk


to a specific procedure

è invasive / less invasive procedure ?

è assumption: less invasive = less risk


© 2010 Universitair Ziekenhuis Gent 18
© 2010 Universitair Ziekenhuis Gent 19
© 2010 Universitair Ziekenhuis Gent 20
pre-operative risk scores

© 2010 Universitair Ziekenhuis Gent 21


Revised Cardiac Risk Index (RCRI or Lee score)
http://www.mdcalc.com/revised-cardiac-risk-index-for-pre-operative-risk/

24 studies including > 790,000 pts

moderately good discrimination of high vs low risk for cardiac


events
è for MIXED non-cardiac surgery
è NOT for VASCULAR non-cardiac surgery
è NOT for predicting mortality
© 2010 Universitair Ziekenhuis Gent 22
AUC for predicting perioperative cardiac events
and all-cause mortality

© 2010 Universitair Ziekenhuis Gent 23


Revised Cardiac Risk Index risk for MACE
1. high risk surgery
(suprainguinal vascular, intraperitoneal, or 0 predictors = 0.4%,
intrathoracic )
2. history of ischemic heart disease
1 predictor = 0.9%,

2 predictors = 6.6%,
3. history of congestive heart failure
≥ 3 predictors = >11%
4. history of cerebrovascular disease
(stroke or transient ischemic attack)

5. history of diabetes requiring insulin


use

6. chronic kidney disease


(creatinine > 1.5 - 2 mg/dL)
© 2010 Universitair Ziekenhuis Gent 24
National Surgical Quality Improvement (NSQIP)
http://www.surgicalriskcalculator.com/miorcardiacarrest

American College of Surgeons multicenter


prospective database including 211,410 pts
© 2010 Universitair Ziekenhuis Gent 25
NSQIP
1. type of surgery
2. dependent functional status
3. abnormal creatinine
4. ASA class
5. increasing age

© 2010 Universitair Ziekenhuis Gent 26


http://riskcalculator.facs.org/

© 2010 Universitair Ziekenhuis Gent 27


è BETTER predictive performance than RCRI
BUT less user-friendly (need for calculation program)

scores provide complementary information

© 2010 Universitair Ziekenhuis Gent 28


perioperative monitoring
electrocardiography

© 2010 Universitair Ziekenhuis Gent 29


© 2010 Universitair Ziekenhuis Gent 30
© 2010 Universitair Ziekenhuis Gent 31
© 2010 Universitair Ziekenhuis Gent 32
© 2010 Universitair Ziekenhuis Gent 33
pharmacological risk reduction strategies

© 2010 Universitair Ziekenhuis Gent 34


© 2010 Universitair Ziekenhuis Gent 35
© 2010 Universitair Ziekenhuis Gent 36
© 2010 Universitair Ziekenhuis Gent 37
others ?

2009

© 2010 Universitair Ziekenhuis Gent 38


others ?

2009

© 2010 Universitair Ziekenhuis Gent 39


intra- and postoperative anesthetic
management

© 2010 Universitair Ziekenhuis Gent 40


intra- and postoperative anesthetic
management

è intra-operative hypotension

è hemodynamic optimization

è intra-operative risk stratification

è anesthetic technique / agent

è identification of patient at risk and


intensification of therapy
© 2010 Universitair Ziekenhuis Gent 41
intra-operative hypotension

© 2010 Universitair Ziekenhuis Gent 42


© 2010 Universitair Ziekenhuis Gent 43
association ≠ causal relationship

è NO evidence that
treatment of hypotension
improves outcome

è hypotension should be
AVOIDED
© 2010 Universitair Ziekenhuis Gent 44
hemodynamic optimization

© 2010 Universitair Ziekenhuis Gent 45


intra-operative risk stratification

10 – point surgical outcomes score

© 2010 Universitair Ziekenhuis Gent 46


© 2010 Universitair Ziekenhuis Gent 47
anesthetic technique / agent

neuraxial techniques

© 2010 Universitair Ziekenhuis Gent 48


2014; CD010108

© 2010 Universitair Ziekenhuis Gent 49


0 – 30 day mortality

© 2010 Universitair Ziekenhuis Gent 50


© 2010 Universitair Ziekenhuis Gent 51
© 2010 Universitair Ziekenhuis Gent 52
therapy intensification

667 consecutive major vascular surgery pts


66 pts suffered postoperative Tn I elevation

therapy was intensified in 43 pts (65 %)

primary endpoint: 12 mnth survival without major cardiac events


© 2010 Universitair Ziekenhuis Gent 53
major cardiac event-free survivial

© 2010 Universitair Ziekenhuis Gent 54


© 2010 Universitair Ziekenhuis Gent 55
conclusions

ü evidence ?

ü complicated ?

ü implementation ?
© 2010 Universitair Ziekenhuis Gent 56

You might also like